Showing results (1891-1900 of 2,996) with videos related to

Sort By:
Pageof 300
Animals : an Open Access Journal From MDPI|October 16, 2025
Wild Birds Pose Unique Food Safety Threats in the US SoutheastSofia Varriano, Jared C Smith, Olivia M Smith, et al.
Frontiers in Oncology|February 15, 2021
Comparison Between Urothelial and Non-Urothelial Urethral CancerMike Wenzel, Marina Deuker, Luigi Nocera, et al.
Clinical Genitourinary Cancer|August 4, 2019
Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate CancerFelix Preisser, Sebastiano Nazzani, Elio Mazzone, et al.
European Urology|March 12, 2014
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic reviewGuillaume Ploussard, Siamak Daneshmand, Jason A Efstathiou, et al.
International Journal of Molecular Sciences|January 8, 2025
Precision Oncology Approach for Urachal Carcinoma: A Clinical Case ReportDániel Juhász, Anita Csizmarik, János Szalontai, et al.
BMC Research Notes|November 4, 2023
Occurrence of some common carbapenemase genes in carbapenem-resistant Klebsiella pneumoniae isolates collected from clinical samples in Tabriz, northwestern IranAbolfazl Jafari-Sales, Noor S K Al-Khafaji, Hussein O M Al-Dahmoshi, et al.
Urologic Oncology|March 27, 2020
The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)Florian Janisch, David D'Andrea, Takehiro Iwata, et al.
Prostate Cancer and Prostatic Diseases|April 13, 2022
Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysisReza Sari Motlagh, Takafumi Yanagisawa, Tatsushi Kawada, et al.
Immunotherapy|September 11, 2023
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysisTakafumi Yanagisawa, Fahad Quhal, Tatsushi Kawada, et al.
European Urology Oncology|January 7, 2022
Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomyEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Pageof 300